Kiniksa Pharmaceuticals
KNSA
#4646
Rank
A$2.44 B
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
$33.68
Share price
-6.43%
Change (1 day)
22.84%
Change (1 year)

Earnings for Kiniksa Pharmaceuticals (KNSA)

Earnings in 2024 (TTM): -A$56.18 Million

According to Kiniksa Pharmaceuticals 's latest financial reports the company's current earnings are A$0.42 Billion. a decrease over its 2023 earnings that were of -A$27.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Kiniksa Pharmaceuticals from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -A$59.8 Million117.1%
2023 -A$27.55 Million-251.02%
2022 A$18.23 M-107.04%
2021 -A$0.26 Billion0.2%
2020 -A$0.26 Billion-4.69%
2019 -A$0.28 Billion58.46%
2018 -A$0.18 Billion59.46%
2017 -A$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion 295.26%๐Ÿ‡บ๐Ÿ‡ธ USA